Search | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Repurposing older drugs to help prevent GVHD

    ... (vorinostat) is safe and results in low incidence of acute graft-versus-host disease (GVHD) after reduced-intensity ... age was 56 years (range, 18-69 years), and 95% had acute myelogenous leukemia or high-risk myelodysplastic syndrome. Vorinostat was ...

    Article last updated 10/18/2017 - 8:48am.

  2. Cellular immune profiling after sequential clofarabine and lenalidomide for high risk myelodysplastic syndromes and acute myeloid leukemia

    ... high risk myelodysplastic syndromes (MDS) and acute myelogenous leukemia (AML) are commonly older with multiple co-morbidities, ...

    Research Article last updated 05/22/2017 - 11:42am.

  3. Drug reduces acute GVHD in unrelated HSCTs

    ... Article Link:  Vorinostat Lowers Acute GVHD in Patients Receiving Unrelated Donor HSCT ... not an easy population. Most of our patients had acute myelogenous leukemia (AML) or myelodysplastic syndrome (MDS), and these are ...

    Article last updated 02/27/2017 - 1:45pm.

  4. Resources to Help

    ... and support for fundraising and patient awareness. Leukemia Research Foundation www.allbloodcancers.org/our-programs ... assistance for Myelodysplastic Syndromes (MDS), Acute Myeloid Leaukemia (AML), Acute Lymphoblastic Leukemia (ALL), ... (800) 366-7741 Offers help to patients with chronic myelogenous leukemia. If you have access to insurance through COBRA, a ...

    Topic section last updated 11/15/2017 - 2:31pm.

  5. Mutational analysis of therapy-related myelodysplastic syndromes and acute myelogenous leukemia

    ... Therapy-related myelodysplastic syndromes and acute myelogenous leukemia (t-MDS/AML) comprise a poor-risk subset of MDS/AML. ...

    Research Article last updated 02/04/2013 - 2:39pm.

  6. Aplastic Anemia and MDS International Foundation (AAMDSIF): Bone marrow failure disease scientific symposium 2016

    ... blood cytopenias and, sometimes, progression to acute myelogenous leukemia . Research efforts have been made all over the world to ...

    Research Article last updated 01/24/2017 - 11:54am.

  7. Resources to Help

    ... and support for fundraising and patient awareness. Leukemia Research Foundation ... assistance for Myelodysplastic Syndromes (MDS), Acute Myeloid Leaukemia (AML), Acute Lymphoblastic Leukemia (ALL), ... (800) 366-7741 Offers help to patients with chronic myelogenous leukemia. If you have access to insurance through COBRA, a ...

    Topic section last updated 09/28/2017 - 11:58am.

  8. Molecular Testing in Patients with Suspected Myelodysplastic Syndromes

    ... and with a propensity to transform to acute myelogenous leukemia . Newer technologies such as next-generation sequencing have ...

    Research Article last updated 11/02/2016 - 10:09am.

  9. Low efficacy and high mortality associated with clofarabine treatment of relapsed/refractory acute myeloid leukemia and myelodysplastic syndromes

    ... has clinical activity in relapsed or refractory acute myelogenous leukemia (AML) and higher-risk myelodysplastic syndromes ...

    Research Article last updated 03/02/2015 - 2:19pm.

  10. Recent advances in the management of therapy-related myelodysplastic syndromes and acute myeloid leukemia.

    ... Therapy-related myelodysplastic syndromes and acute myelogenous leukemia (t-MDS/AML) comprise an increasingly common, poor-risk ...

    Research Article last updated 02/04/2013 - 2:51pm.